Estudio de fármacos inhibidores de autofagia y epigenéticos en una línea celular de cáncer de próstata
Contenido principal del artículo
Resumen
Palabras clave:
Descargas
Detalles del artículo
Citas
Arroyo DS, Gaviglio EA, Peralta-Ramos JM, Bussi C, Rodríguez-Galán MC, Iribarren P. Autophagy in inflammation, infection, neurodegeneration and cancer. Int Immunopharmacol. 2014; 18(1): 55-65.
Hardy TM, Tollefsbol TO. Epigenetic diet: impact on the epigenome and cancer. Epigenomics. 2011; 3(4): 503-18.
He C, Klionsky DJ. Regulation Mechanisms and Signaling Pathways of Autophagy. Annu Rev Genet. 2009; 43: 67-93.
Kimmelman AC. The dynamic nature of autophagy in cancer. Genes & Development. 2011; 25(19): 1999-2010.
Kouznetsov VV, Amado Torres DF. Antimaláricos: construcción de híbridos moleculares de la cloroquina. Univ Sci. 2008; 13(3): 306-20.
Li X, Zhang J, Xie Y, Jiang Y, Yingjie Z, Xu W. Progress of HDAC inhibitor panobinostat in the treatment of cancer. Curr Drug Targets. 2014; 15(6): 622-34.
Mizushima N, Levine B, Cuervo AM, Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature. 2008; 451(7182): 1069-75.
Pascolo S. Time to use a dose of Chloroquine as an adjuvant to anti-cancer chemotherapies. Eur J Pharmacol. 2016; 771: 139-44.
Rao R, Balusu R, Fiskus W, Mudunuru U, Venkannagari S, Chauhan L, et al. Combination of pan-histone deacetylase inhibitor and autophagy inhibitor exerts superior efficacy against triple-negative human breast cancer cells. Mol Cancer Ther. 2012; 11(4): 973-83.
Santini V, Gozzini A, Ferrari G. Histone deacetylase inhibitors: molecular and biological activity as a premise to clinical application. Curr Drug Metab. 2007; 8(4): 383-93.
Sharma S, Witteveen PO, Lolkema MP, Hess D, Gelderblom H, Hussain SA, et al. A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function. Cancer Chemother Pharmacol. 2015; 75(1): 87-95.
Stephenson L. Autophagy in cancer promotes Therapeutic Resistance. Biofiles. 2013; 8(9).
Vaissière T, Sawan C, Herceg Z. Epigenetic interplay between histone modifications and DNA methylation in gene silencing. Mutat Res. 2008; 659(1-2): 40-8.
Yen C-Y, Huang H-W, Shu C-W, Hou M-F, Yuan S-SF, Wang H-R, et al. DNA methylation, histone acetylation and methylation of epigenetic modifications as a therapeutic approach for cancers. Cancer Lett. 2016; 373(2): 185-92.
Zhang Y, Liao Z, Zhang L, Xiao H. The utility of chloroquine in cancer therapy. Curr Med Res. 2015; 31(5): 1009-13.